Frontiers in Pharmacology | Neuropharmacology

Mini Review

Published on 30 Nov 2022

Selective Vulnerability of the Locus Coeruleus Noradrenergic System and its Role in Modulation of Neuroinflammation, Cognition, and Neurodegeneration

in Neuropharmacology

Andrew K. Evans
Erwin Defensor
Mehrdad Shamloo

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1030609

5,597 views
13 citations

Review

Published on 29 Nov 2022

Noble gas and neuroprotection: From bench to bedside

in Neuropharmacology

Haiying Yin
Zijun Chen
Hailin Zhao
Han Huang
Wenwen Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1028688

6,094 views
20 citations

Review

Published on 28 Nov 2022

New developments and opportunities in drugs being trialed for amyotrophic lateral sclerosis from 2020 to 2022

in Neuropharmacology

JingSi Jiang
Yan Wang
Min Deng

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1054006

26,045 views
53 citations

Original Research

Published on 28 Nov 2022

Adolescent kratom exposure affects cognitive behaviours and brain metabolite profiles in Sprague-Dawley rats

in Neuropharmacology

Aiman Nadhirah Zul Aznal
Nurul Aqmar Mohamad Nor Hazalin
Zurina Hassan
Noorul Hamizah Mat
Nelson Jeng-Yeou Chear
Lay Kek Teh
Mohd Zaki Salleh
Farah Wahida Suhaimi

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1057423

6,879 views
9 citations

Original Research

Published on 24 Nov 2022

Bioinformatics analysis and in vivo validation of ferroptosis-related genes in ischemic stroke

in Neuropharmacology

Chang Liu
Zhixi Li
Hongjie Xi

Frontiers in Pharmacology

doi 10.3389/fphar.2022.940260

14,045 views
25 citations

Review

Published on 24 Nov 2022

Research progress in traditional Chinese medicine in the treatment of Alzheimer’s disease and related dementias

in Neuropharmacology

Wanying Tan
Lingjun Qi
Xiaoyu Hu
Zhenghuai Tan

Frontiers in Pharmacology

doi 10.3389/fphar.2022.921794

8,165 views
30 citations

Systematic Review

Published on 24 Nov 2022

Adverse event profiles of adjuvant treatment with opicapone in Parkinson’s disease: A systematic review and meta-analysis

in Neuropharmacology

Luwen Xie
Xiaoyi Qi
Xuan Wang
Bing He
Yu Wang
Wei Zhang
Zehui Yu
Mingming Deng
Sicheng Liang
Muhan Lü

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1042992

3,004 views
3 citations

Original Research

Published on 23 Nov 2022

Doxycycline attenuates l-DOPA-induced dyskinesia through an anti-inflammatory effect in a hemiparkinsonian mouse model

in Neuropharmacology

Maurício dos Santos Pereira
Glauce Crivelaro do Nascimento
Mariza Bortolanza
Patrick Pierre Michel
Rita Raisman-Vozari
Elaine Del Bel

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1045465

3,871 views
14 citations

Original Research

Published on 23 Nov 2022

AA147 ameliorates post-cardiac arrest cerebral ischemia/reperfusion injury through the co-regulation of the ATF6 and Nrf2 signaling pathways

in Neuropharmacology

Zhu Yuan
Liping Lu
Yingtao Lian
Yuanrui Zhao
Tingting Tang
Song Xu
Zhun Yao
Zhui Yu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1028002

4,190 views
22 citations

Original Research

Published on 23 Nov 2022

The differential in vivo contribution of spinal α2A- and α2C-adrenoceptors in tonic and acute evoked nociception in the rat

in Neuropharmacology

Gustavo López-Córdoba
Guadalupe Martínez-Lorenzana
Jair Lozano-Cuenca
Miguel Condés-Lara
Abimael González-Hernández

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1023611

7,673 views
2 citations

Correction

Published on 18 Nov 2022

Corrigendum: Striatal dopamine D2-muscarinic acetylcholine M1 receptor-receptor interaction in a model of movement disorders

in Neuropharmacology

René A. J. Crans
Elise Wouters
Marta Valle-León
Jaume Taura
Caio M. Massari
Víctor Fernández-Dueñas
Christophe P. Stove
Francisco Ciruela

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1075433

981 views

Editorial

Published on 18 Nov 2022

Editorial: Treatment of Alzheimer’s disease-discovery of natural products based on neurite outgrowth and neuroprotection

in Neuropharmacology

Zhiyou Yang
Cai Song
Yue-Wei Ge
Chihiro Tohda

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1079783

2,005 views
1 citation

Original Research

Published on 18 Nov 2022

Buprenorphine exposure levels to optimize treatment outcomes in opioid use disorder

in Neuropharmacology

Celine M. Laffont
Eliford Ngaimisi
Mathangi Gopalakrishnan
Vijay Ivaturi
Malcolm Young
Mark K. Greenwald
Christian Heidbreder

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1052113

8,358 views
20 citations

Review

Published on 18 Nov 2022

Gαs, adenylyl cyclase, and their relationship to the diagnosis and treatment of depression

in Neuropharmacology

Jeffrey M. Schappi
Mark M. Rasenick

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1012778

3,946 views
6 citations

Clinical Trial

Published on 18 Nov 2022

Low-dose naloxone for prophylaxis of sufentanil-induced choking and postoperative nausea and vomiting

in Neuropharmacology

Yiling Qian
Zhifei Huang
Guilong Wang
Jinghong Han
Difei Zhou
Hailei Ding
Xin Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1050847

3,095 views
11 citations

Review

Published on 17 Nov 2022

Treatment of ADHD: Drugs, psychological therapies, devices, complementary and alternative methods as well as the trends in clinical trials

in Neuropharmacology

Victoria A. Nazarova
Aleksandr V. Sokolov
Vladimir N. Chubarev
Vadim V. Tarasov
Helgi B. Schiöth

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1066988

77,921 views
48 citations